Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Bempedoic Acid

Bempedoic Acid: A Comprehensive Overview

Introduction

Bempedoic acid is a novel lipid-lowering agent developed to help individuals manage high cholesterol and reduce the risk of cardiovascular events. It is part of a growing class of non-statin medications used in the treatment of hyperlipidemia, specifically for patients who are unable to achieve adequate cholesterol control with statins alone or those who cannot tolerate statin therapy due to its side effects. Bempedoic acid offers an alternative mechanism of action for managing elevated cholesterol levels, particularly low-density lipoprotein cholesterol (LDL-C), which is often associated with an increased risk of heart disease and stroke.

Bempedoic Acid:

Bempedoic acid, marketed under the brand name Nexletol, is a non-statin cholesterol-lowering medication. It works by inhibiting an enzyme known as ATP-citrate lyase (ACL), which is involved in the synthesis of cholesterol in the liver. By blocking ACL, bempedoic acid reduces the production of cholesterol, specifically low-density lipoprotein cholesterol (LDL-C), the type of cholesterol most strongly linked to atherosclerosis and cardiovascular disease. Unlike statins, which inhibit the HMG-CoA reductase enzyme (another key enzyme in cholesterol synthesis), bempedoic acid works upstream in the cholesterol biosynthesis pathway, which offers an important alternative for individuals who may not tolerate statins or require additional lipid-lowering therapy.

Mechanism of Action

The primary mechanism of action of bempedoic acid is the inhibition of ATP-citrate lyase (ACL). ACL is an enzyme located in the liver that plays a crucial role in the conversion of citrate to acetyl-CoA, which is a precursor for cholesterol synthesis. By inhibiting ACL, bempedoic acid decreases the amount of acetyl-CoA available, thereby reducing the production of cholesterol, particularly LDL-C.

This inhibition of ACL leads to several important physiological effects:

  1. Reduction in Cholesterol Synthesis: By decreasing the hepatic production of cholesterol, bempedoic acid helps lower blood levels of LDL-C, a key contributor to the development of atherosclerosis.

  2. Increased LDL Receptor Activity: As a result of the decrease in hepatic cholesterol synthesis, the liver compensates by increasing the number of LDL receptors on its cell surfaces. This increases the clearance of LDL-C from the bloodstream, further contributing to lower cholesterol levels.

  3. Reduced Inflammatory Responses: Elevated levels of LDL-C are associated with inflammation within the vascular walls, which promotes the development of plaque and atherosclerosis. By reducing LDL-C levels, bempedoic acid may indirectly reduce this inflammatory response and decrease the progression of atherosclerosis.

Clinical Applications of Bempedoic Acid

Bempedoic acid is primarily prescribed as a lipid-lowering therapy to help reduce LDL-C levels in individuals with hyperlipidemia. It is often used when statin therapy is not sufficient or not tolerated due to side effects such as muscle pain, liver enzyme abnormalities, or other adverse reactions. Bempedoic acid has demonstrated its efficacy in clinical trials for lowering LDL-C levels and, more importantly, for reducing the risk of cardiovascular events.

1. Hyperlipidemia and Dyslipidemia

The primary indication for bempedoic acid is the treatment of hyperlipidemia—a condition characterized by high levels of cholesterol or other lipids in the blood. Specifically, bempedoic acid targets elevated LDL-C levels, which are associated with an increased risk of heart disease and stroke. This condition is often managed with statins, but for individuals who cannot tolerate statins or need additional cholesterol-lowering therapy, bempedoic acid provides an alternative. Bempedoic acid is typically prescribed when statins alone are insufficient or when combination therapy is required to achieve the recommended LDL-C targets. It may be used alongside ezetimibe (which reduces cholesterol absorption) or other lipid-lowering agents.

2. Cardiovascular Disease Prevention

One of the most important roles of bempedoic acid is in preventing cardiovascular events. Elevated LDL-C levels are a major risk factor for atherosclerosis, which can lead to heart attacks, strokes, and peripheral artery disease. By lowering LDL-C levels, bempedoic acid helps reduce the risk of these cardiovascular events. Clinical studies have demonstrated that bempedoic acid not only lowers LDL-C but may also have a cardioprotective effect, potentially reducing the incidence of major adverse cardiovascular events (MACE), including myocardial infarction and stroke. In patients with established cardiovascular disease (CVD), including those who have had a heart attack or stroke, bempedoic acid may be added to therapy as part of a comprehensive strategy to reduce the risk of recurrent events.

3. Statin-Intolerant Patients

A significant number of individuals experience side effects from statin therapy, particularly muscle pain or myopathy. For these patients, who are often unable to achieve optimal cholesterol control with statins, bempedoic acid offers an alternative. Since bempedoic acid works via a different mechanism than statins, it is well-tolerated by individuals who cannot tolerate statins. Bempedoic acid is often used in combination therapy with other lipid-lowering agents, such as ezetimibe, in these statin-intolerant patients to achieve the desired reduction in LDL-C levels.

Efficacy of Bempedoic Acid

The efficacy of bempedoic acid has been evaluated in several clinical trials, with significant reductions in LDL-C levels being consistently reported. Bempedoic acid has been shown to lower LDL-C by approximately 20% to 30% in patients with elevated cholesterol, with some studies showing even greater reductions in those with more severe hyperlipidemia. One of the largest clinical trials examining bempedoic acid is the CLEAR Wisdom trial, which evaluated the effect of bempedoic acid on cardiovascular outcomes in patients with hyperlipidemia and established cardiovascular disease. The trial demonstrated that bempedoic acid not only reduced LDL-C but also significantly reduced the risk of major adverse cardiovascular events (MACE), including heart attack and stroke, when compared to placebo. This promising evidence suggests that bempedoic acid may be an important adjunct in the prevention of cardiovascular events, particularly for patients who are unable to tolerate statins or need additional treatment to reach their cholesterol targets.

Side Effects and Safety Profile

While bempedoic acid is generally well-tolerated, like all medications, it carries a risk of side effects. Most side effects associated with bempedoic acid are mild to moderate and occur in a small percentage of patients. Below is a summary of the potential side effects:

1. Common Side Effects

  • Musculoskeletal Pain: Some individuals may experience muscle pain, which is generally less common and less severe than the muscle-related side effects associated with statins.

  • Abdominal Pain: Some patients report mild abdominal discomfort or indigestion.

  • Fatigue: A small percentage of patients may experience fatigue or low energy levels.

2. Serious Side Effects

  • Tendon Rupture: In rare cases, bempedoic acid has been associated with an increased risk of tendon injuries or tendon ruptures, a condition more commonly seen with statins.

  • Liver Enzyme Elevations: Bempedoic acid has been associated with mild elevations in liver enzymes in some individuals, although these are generally not severe enough to require discontinuation of therapy.

  • Gout: There have been reports of gout flare-ups in some patients taking bempedoic acid, likely due to an increase in uric acid levels.

  • Hyperglycemia: As with many other cholesterol-lowering medications, bempedoic acid may increase blood glucose levels in some individuals, although this is typically modest.

Given its side effect profile, patients starting on bempedoic acid should be regularly monitored for liver function, musculoskeletal issues, and blood sugar levels. In patients with pre-existing kidney or liver conditions, caution may be advised.

Bempedoic Acid in Combination Therapy

One of the key benefits of bempedoic acid is its ability to be used in combination therapy with other cholesterol-lowering drugs, particularly statins and ezetimibe. For patients who are unable to tolerate high doses of statins or who require additional cholesterol reduction, combining bempedoic acid with other agents can achieve significant LDL-C reductions. For example, the combination of bempedoic acid and ezetimibe has been shown to be particularly effective in lowering LDL-C levels without the risk of statin-related side effects. This combination approach allows for more comprehensive control of cholesterol and is often prescribed for patients at high cardiovascular risk.

Future Directions and Research

The future of cholesterol management may involve a more personalized approach, incorporating a variety of lipid-lowering agents, including bempedoic acid, to target different aspects of cholesterol metabolism. Ongoing research is investigating the long-term effects of bempedoic acid on cardiovascular outcomes, including whether it can reduce the risk of stroke, heart attack, and other major events in different patient populations. Additionally, new combination therapies that include bempedoic acid are under investigation. These combinations may offer enhanced efficacy while reducing the need for high-dose statins, which are associated with more side effects.

Conclusion

Bempedoic acid represents an important advancement in the treatment of hyperlipidemia and cardiovascular disease prevention, offering an effective and well-tolerated option for individuals who are either statin-intolerant or require additional cholesterol-lowering therapy. With its ability to reduce LDL-C levels, bempedoic acid helps to lower the risk of atherosclerosis and related cardiovascular events, making it a valuable tool in the fight against heart disease and stroke. As research continues and new combination therapies emerge, bempedoic acid is likely to play an increasingly important role in personalized lipid-lowering strategies, contributing to better cardiovascular outcomes and improving the quality of life for patients at risk of cardiovascular disease.